UK Markets closed

Lysogene S.A. (LYSGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.50000.0000 (0.00%)
At close: 09:57AM EST
Full screen
Trade prices are not sourced from all markets
Previous close3.5000
Open3.5000
BidN/A x N/A
AskN/A x N/A
Day's range3.5000 - 3.5000
52-week range2.4100 - 3.5000
Volume1,500
Avg. volume0
Market cap58.767M
Beta (5Y monthly)0.48
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Lysogene Secures a €4.3 Million Non-dilutive Financing From Bpifrance to Support Its Development

    PARIS, November 26, 2021--Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announced today that it has secured a €4.3 million non-dilutive financing from Bpifrance.

  • Business Wire

    Lysogene Announces a Presentation of its LYS-GM101 Program at the ESGCT 2021

    PARIS, October 18, 2021--Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces today that it will give an oral presentation at the ESGCT 2021 Annual Virtual Conference on its gene therapy drug candidate LYS-GM101 in GM1 gangliosidosis.

  • Business Wire

    Lysogene Reports its Cash Position as of 30 September 2021

    PARIS, October 08, 2021--Regulatory News: Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today reports its cash position of €9.5 million1 as of 30 September 2021 (compared to €15.0 million as of 30 June 2021).